Search

Search Constraints

You searched for: Author/Creator Fox, Keith A. A.

Search Results

1. Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial. Issue 3 (3rd March 2015)

2. Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial. Issue 3 (March 2015)

3. Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. Issue 3 (8th March 2016)

4. Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. Issue 3 (March 2016)

5. Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Issue 11 (3rd November 2017)

6. Effect of PSI‐697, a Novel P‐Selectin Inhibitor, on Platelet–Monocyte Aggregate Formation in Humans. Issue 1 (28th January 2013)

7. Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States. Issue 3 (19th March 2015)

8. Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States. Issue 3 (March 2015)

9. Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial. Issue 1 (19th February 2013)

10. Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. (July 2019)